Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01898208 · ClinicalTrials.gov registry record · NA
Rapid Identification and Susceptibility Testing of Pathogens From Blood Cultures
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 743
- Enrollment target
NCT01898208: Completed NA study, sponsored by Mayo Clinic.
NCT01898208 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 743 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01898208, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 743 participants
- Enrollment target
Study Summary
Would rapid identification of bacteria and rapid detection of methicillin-resistant S. aureus (MRSA) and vancomycin-resistant enterococci (VRE) (using an FDA-cleared assay) in positive blood culture bottles improve patient care at Mayo Clinic Rochester (or just lead to increased cost)?
Primary Outcome
Difference between the date and time of the antibiotic start order (or Gram stain-positive blood culture, if antibiotics were started prior to the positive culture result) and the date and time of the antibiotic stop order. Shorter duration of broad spectrum antibiotics and longer duration of narrow-spectrum antibiotics were considered favorable outcomes.
Interventions
- DEVICE FilmArray testing
- BEHAVIORAL Antimicrobial Stewardship
- OTHER Bacterial culture
- OTHER Susceptibility testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 743 participants |
| Start Date | 2013-08 |
| Est. Completion | 2014-08 |
| Phase | NA |
What the finished NCT01898208 record still lists
NCT01898208 is an interventional study that assigns participants to a tested intervention. The registered 743 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% lower).
The record links to 0 conditions, and to 4 interventions - of which FilmArray testing is the first listed.
NCT01898208 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01898208 about?
NCT01898208 is a clinical study titled "Rapid Identification and Susceptibility Testing of Pathogens From Blood Cultures". Would rapid identification of bacteria and rapid detection of methicillin-resistant S. aureus (MRSA) and vancomycin-resistant enterococci (VRE) (using an FDA-cleared assay) in positive blood culture bottles improve patient care at Mayo Clinic Rochester (or just lead to increased cost)?
What is the current status of trial NCT01898208?
This trial is currently completed. It is a NA study. The enrollment target is 743 participants. The study started on 2013-08. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01898208?
The interventions under investigation include: FilmArray testing (DEVICE), Antimicrobial Stewardship (BEHAVIORAL), Bacterial culture (OTHER), Susceptibility testing (OTHER).
Who is sponsoring clinical trial NCT01898208?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01898208's enrollment target sits among peer trials
743 145th of 2000 higher than 1,856 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05619185 · 744 participants · NA
A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners
- NCT06417814 · 744 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- NCT07046351 · 744 participants · NA
weSIPsmarter: Evaluating a Digital Health Intervention Aimed at Reducing Sugary Drinks Among Rural Head Start Preschoolers and Their Parents
- NCT07199569 · 744 participants · Phase 2
Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia